Tissue Regenix Company

Tissue Regenix was founded in May 2006, to commercialise innovative technologies in regenerative medicine. The underpinning science was developed over the last decade in the world-leading Institute for Medical and Biological Engineering at the University of Leeds by Professors John Fisher and Eileen Ingham. The research has received in excess of £4 million grant funding to date from UK research councils (EPSRC, BBSRC) and the Children's Heart Surgery Fund.
Technology: Regenerative Medicine
Industry: Regenerative Medicine
Headquarters: York, York, United Kingdom
Founded Date: 2006
Employees Number: 51-100
Funding Status: IPO

Visit Website
enquiries@tissueregenix.com
@tissue_regenix
Register and Claim Ownership